Inventor
RASHID RUMANA
US55 patents
⚠️ This page may combine multiple inventors who share the name “RASHID RUMANA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
XENCOR INC
49 patentsUS9856327B2Jan 2, 2018
Heterodimeric antibodies to CD3 X CD123
XENCOR INC72 citations98
US9701759B2Jul 11, 2017
Heterodimeric proteins
XENCOR INC48 citations98
US9650446B2May 16, 2017
Heterodimeric proteins
XENCOR INC44 citations98
US9605084B2Mar 28, 2017
Heterodimeric proteins
XENCOR INC74 citations98
US11225528B2Jan 18, 2022
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC11 citations94
US10550185B2Feb 4, 2020
Bispecific heterodimeric fusion proteins containing IL-15-IL-15Rα Fc-fusion proteins and PD-1 antibody fragments
XENCOR INC29 citations94
US10526417B2Jan 7, 2020
Heterodimeric antibodies that bind CD3 and CD38
XENCOR INC27 citations94
US10259887B2Apr 16, 2019
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC25 citations94
US10501543B2Dec 10, 2019
IL15/IL15Rα heterodimeric Fc-fusion proteins
XENCOR INC13 citations92
US9850320B2Dec 26, 2017
Heterodimeric antibodies to CD3 X CD20
XENCOR INC13 citations92
US11505595B2Nov 22, 2022
TIM-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion proteins and TIM-3 antigen binding domains
XENCOR INC9 citations86
US11377477B2Jul 5, 2022
PD-1 targeted IL-15/IL-15RALPHA fc fusion proteins and uses in combination therapies thereof
XENCOR INC7 citations85
US11358999B2Jun 14, 2022
IL-12 heterodimeric Fc-fusion proteins
XENCOR INC12 citations85
US11225521B2Jan 18, 2022
Heterodimeric antibodies that bind somatostatin receptor 2
XENCOR INC11 citations85
US11472890B2Oct 18, 2022
Heterodimeric antibodies that bind ENPP3 and CD3
XENCOR INC9 citations84
US11319355B2May 3, 2022
Engineered IL-2 Fc fusion proteins
XENCOR INC5 citations84
US11053316B2Jul 6, 2021
Optimized antibody variable regions
XENCOR INC7 citations84
US10858417B2Dec 8, 2020
Heterodimeric proteins
XENCOR INC7 citations84
US10738133B2Aug 11, 2020
Heterodimeric proteins
XENCOR INC9 citations84
US10738132B2Aug 11, 2020
Heterodimeric proteins
XENCOR INC9 citations84
US10316088B2Jun 11, 2019
Heterodimeric antibodies that bind somatostatin receptor 2
XENCOR INC11 citations84
US10131710B2Nov 20, 2018
Optimized antibody variable regions
XENCOR INC15 citations84
US10106624B2Oct 23, 2018
Heterodimeric proteins
XENCOR INC7 citations84
US12239688B2Mar 4, 2025
IL-15/IL-15RA heterodimeric Fc fusion proteins and uses thereof
XENCOR INC2 citations75
US11618776B2Apr 4, 2023
Targeted heterodimeric Fc fusion proteins containing IL-15/IL-15RA and NKG2D antigen binding domains
XENCOR INC4 citations75
US11945880B2Apr 2, 2024
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC1 citations73
US11859011B2Jan 2, 2024
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC1 citations73
US11634506B2Apr 25, 2023
Heterodimeric proteins
XENCOR INC2 citations73
US11584794B2Feb 21, 2023
Bispecific heterodimeric fusion proteins containing IL-15-IL-15Ralpha Fc-fusion proteins and immune checkpoint antibody fragments
XENCOR INC2 citations73
US11524991B2Dec 13, 2022
PD-1 targeted heterodimeric fusion proteins containing IL-15/IL-15Ra Fc-fusion proteins and PD-1 antigen binding domains and uses thereof
XENCOR INC5 citations73
US11352442B2Jun 7, 2022
Heterodimeric antibodies that bind CD3 and CD38
XENCOR INC2 citations73
US11299554B2Apr 12, 2022
Heterodimeric proteins
XENCOR INC3 citations73
US10968276B2Apr 6, 2021
Optimized anti-CD3 variable regions
XENCOR INC6 citations73
US10913803B2Feb 9, 2021
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC1 citations73
US10889653B2Jan 12, 2021
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC2 citations73
US10851178B2Dec 1, 2020
Heterodimeric human IgG1 polypeptides with isoelectric point modifications
XENCOR INC2 citations73
US11851466B2Dec 26, 2023
Targeted IL-12 heterodimeric Fc-fusion proteins
XENCOR INC3 citations72
US11655277B2May 23, 2023
IL-12 heterodimeric Fc-fusion proteins
XENCOR INC2 citations72
US12509495B2Dec 30, 2025
LAG-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion proteins and LAG-3 antigen binding domains
XENCOR INC1 citations64
US12415849B2Sep 16, 2025
Heterodimeric proteins
XENCOR INC0 citations63
US11814423B2Nov 14, 2023
Heterodimeric proteins
XENCOR INC0 citations63
US11718667B2Aug 8, 2023
Optimized antibody variable regions
XENCOR INC0 citations63
US10487155B2Nov 26, 2019
Heterodimeric proteins
XENCOR INC1 citations63
US12448423B2Oct 21, 2025
Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domains
XENCOR INC0 citations62
US12359002B2Jul 15, 2025
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC0 citations62
US12234270B2Feb 25, 2025
IL-12 heterodimeric Fc-fusion proteins
XENCOR INC0 citations62
US12129309B2Oct 29, 2024
Heterodimeric antibodies that bind CD3 and CD38
XENCOR INC0 citations62
US12054545B2Aug 6, 2024
Heterodimeric antibodies that bind somatostatin receptor 2
XENCOR INC0 citations62
US12006345B2Jun 11, 2024
Untargeted and targeted IL-10 Fc-fusion proteins
XENCOR INC0 citations62
GENENTECH INC
1 patentShowing the top 50 of 55 patents by PatentIndex Score.